Browse By

All posts by Kane Biotech

Kane Biotech Announces 2023 Achievements

Kane aims to disrupt global wound care hydrogel market with its first FDA cleared medical device and announces new partnerships and licensing agreements  Kane Biotech has announced several partnerships and licensing agreements in both wound care and animal health in 2023. The recent announcement of

Kane Biotech in the News 2023

In 2023, Kane Biotech has been featured in several news media articles, including  BNN Bloomberg and Benzinga, as well as a podcast with proactiveinvestors.com. Kane is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. With a

Kane Biotech: A Year in Review 2022

As 2022 draws to a close, Kane Biotech reflects upon its achievements in the last year. Kane refers to itself as THE Biofilm Company, with over 80 patents and patents pending. Kane focused its efforts in 2022 on further developing its wound care product pipeline